-
Mashup Score: 0For Some Cancers, Black Patients Have Lower Survival Rates Than White Patients - Oncology Nurse Advisor - 3 day(s) ago
Researchers found that cancer incidence is on the decline for Black patients and rising for White patients, but mortality is on the decline for both groups.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 0Recurrent Laryngeal Nerve Injury Risk Decreases With IONM in Thyroidectomy - Oncology Nurse Advisor - 4 day(s) ago
Researchers conducted a retrospective cohort study to assess the association between intraoperative nerve monitoring and postoperative outcomes in thyroidectomy.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
Use of intraoperative nerve monitoring (IONM) during #thyroidectomy is associated with a slight reduction in the odds of recurrent laryngeal nerve injury. Published in the @JAMAOto and @EndoAdvisor. https://t.co/H2k8ELpXlN
-
-
Mashup Score: 1Metastatic Urothelial Carcinoma Immunotherapy Outcomes Better With Antihistamines - Oncology Nurse Advisor - 17 day(s) ago
The role of histamine is being investigated across several cancer types.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
Antihistamine use concomitant with second-line atezolizumab immunotherapy was associated with longer progression-free, cancer-free, and overall survival among patients with metastatic #urothelialCarcinoma. From @renalandurology. https://t.co/NQqAR6xpH7
-
-
Mashup Score: 0Journavx, a Nonopioid Oral Pain Medication, Gets FDA Approval - Oncology Nurse Advisor - 26 day(s) ago
The active ingredient in Journavx is suzetrigine, a sodium channel blocker.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
The @FDA has approved Journavx™ (suzetrigine) for the treatment of moderate to severe acute #pain in adults. https://t.co/JndghzSmJS #cancerpain
-
-
Mashup Score: 0Research Suggests Caregivers Could Benefit from Extra Support During CAR-T Therapy - Oncology Nurse Advisor - 27 day(s) ago
Interviews revealed what patients and their caregivers focus on and needed support throughout the CAR-T therapy trajectory.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
Additional support for #caregivers of patients who have recently undergone CAR-T therapy could reduce some of the stress associated with the requirement to maintain a constant presence. https://t.co/oc1xz0Kdvh
-
-
Mashup Score: 0Nurse-Led Counseling, Care Reduced Complications Following Gastric Cancer Surgery - Oncology Nurse Advisor - 28 day(s) ago
In a comparison study, benefits of nurse-led preoperative counseling and follow-up care was significantly greater compared with surgeon-led or no counseling models.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
Patients undergoing radical gastrectomy for #gastricCancer benefited significantly from structured preoperative counseling and postoperative follow-up, particularly when led by nurses. https://t.co/rVyrueeG3V #OncNurse
-
-
Mashup Score: 0Epirubicin/Mindfulness Intervention Improved Outcomes in Urinary Tumor Patients - Oncology Nurse Advisor - 29 day(s) ago
Researchers compared the effects of conventional treatment with a combination of epirubicin and mindfulness intervention on oncologic and psychologic burden in patients with urinary tract cancers.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
Epirubicin combined with mindfulness intervention significantly improved clinical outcomes in patients with urinary system #tumors and depression, demonstrating its potential for broader clinical application. https://t.co/nC6MtGwqp6
-
-
Mashup Score: 0
The pembrolizumab-THP regimen “was safe and improved pathological complete response beyond standard-of-care THP, but it did not mitigate the need for dual HER2 blockade,” said Heather McArthur, MD.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
Adding pembrolizumab to neoadjuvant treatment with THP improved pCR rates in patients with HER2-positive #breastcancer in the phase 2 NeoHIP trial. Presented at @SABCSSanAntonio #SABCS24, reported by @CancerTherAdvsr. https://t.co/cqiZupvA54 #bcsm
-
-
Mashup Score: 0Adjuvant Multi-Agent Chemotherapy Extends OS in Pancreatic Cancer - Oncology Nurse Advisor - 1 month(s) ago
Single-agent adjuvant chemotherapy did not improve overall survival when compared to no adjuvant chemotherapy.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
Adjuvant multi-agent chemotherapy can improve OS when compared to adjuvant single-agent chemotherapy or no adjuvant chemotherapy in patients with #pancreaticCancer. Published in @JAMAOnc. and @cancertheradvsr. https://t.co/3e0JswkLUw #pancsm
-
-
Mashup Score: 0Patient-Centered Cancer Care Improved Through Nutrition Support - Oncology Nurse Advisor - 1 month(s) ago
This report on nutrition among patients with cancer highlights current and potential roles for oncology nurses in incorporating nutrition care into cancer care.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
#OncologyNurses are uniquely positioned to provide nutrition care throughout the trajectory of #cancerTreatment, ensuring that patients receive the support necessary to optimize clinical outcomes. Published in @SemOncNurs. https://t.co/DPTwfbKvuz #oncnurse
-
Although overall #cancermortality rates are declining for Black patients in the United States, Black patients continue to have higher mortality rates than White patients for some cancers. Published in @CACancerJournal and @CancerTherAdvsr. https://t.co/RCgytdzmW1 #cancerdeath… https://t.co/C5srAYfP3w